Glucose challenge increases circulating progenitor cells in Asian Indian male subjects with normal glucose tolerance which is compromised in subjects with pre-diabetes: A pilot study

BMC Endocrine Disorders

Volumn 11, Issue , 2011, Pages

  Nathan, Abel A ^a   Mohan, Viswanathan ^b   Babu, Subash S ^c,d   Bairagi, Soumi ^a   Dixit, Madhulika ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

^c SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CREATININE; GLUCOSE; INSULIN;

ADULT; ARTICLE; ASIAN; ATTENUATION; CD34 SELECTION; CELL COUNT; CELL TYPE; CIRCULATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET RESTRICTION; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NEUTROPHIL COUNT; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY;

EID: 78651091227     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-11-2     Document Type: Article

References (27)

1. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105:369-377. 10.1016/S0092-8674(01)00328-2, 11348593.
2. Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003, 108:2070-2073. 10.1161/01.CIR.0000099501.52718.70, 14568894.
3. Abrahamsen JF, Smaaland R, Sothern RB, Laerum OD. Variation in cell yield and proliferative activity of positive selected human CD34+ bone marrow cells along the circadian time scale. Eur J Haematol 1998, 60:7-15. 10.1111/j.1600-0609.1998.tb00990.x, 9451422.
4. Grundmann F, Scheid C, Braun D, Zobel C, Reuter H, Schwinger RH, Muller-Ehmsen J. Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction. Clin Res Cardiol 2007, 96:621-627. 10.1007/s00392-007-0543-7, 17676354.
5. Fadini GP, de KS, Albiero M, Coracina A, Pagnin E, Baesso I, Cignarella A, Bolego C, Plebani M, Nardelli GB, Sartore S, Agostini C, Avogaro A. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008, 28:997-1004. 10.1161/ATVBAHA.107.159558, 18276910.
6. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004, 164:1422-1426. 10.1001/archinte.164.13.1422, 15249351.
7. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de KS, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006, 26:2140-2146. 10.1161/01.ATV.0000237750.44469.88, 16857948.
8. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194:46-54. 10.1016/j.atherosclerosis.2007.03.046, 17493626.
9. Fadini GP, Boscaro E, de KS, Agostini C, Seeger F, Dimmeler S, Zeiher A, Tiengo A, Avogaro A. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 2010, 33:1097-1102. 10.2337/dc09-1999, 20150295.
10. Jung C, Rafnsson A, Shemyakin A, Bohm F, Pernow J. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010, 143:368-372. 10.1016/j.ijcard.2009.03.075, 19398138.
11. Murphy C, Kanaganayagam GS, Jiang B, Chowienczyk PJ, Zbinden R, Saha M, Rahman S, Shah AM, Marber MS, Kearney MT. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 2007, 27:936-942. 10.1161/01.ATV.0000258788.11372.d0, 17255539.
12. Dessapt C, Karalliedde J, Hernandez-Fuentes M, Martin PP, Maltese G, Dattani N, Atkar R, Viberti G, Gnudi L. Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care 2010, 33:875-877. 10.2337/dc09-1468, 20067966.
13. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005, 45:1449-1457. 10.1016/j.jacc.2004.11.067, 15862417.
14. Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A, Di SR, Miccoli R, de KS, Coracina A, Tiengo A, Agostini C, Del PS, Avogaro A. Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 2007, 50:2156-2163. 10.1007/s00125-007-0732-y, 17579827.
15. Bonora E. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives. Int J Clin Pract Suppl 2002, 5-11.
16. Meigs JB, Nathan DM, D'Agostino RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002, 25:1845-1850. 10.2337/diacare.25.10.1845, 12351489.
17. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999, 354:617-621. 10.1016/S0140-6736(98)12131-1, 10466661.
18. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, Akhmetshina A, Walker UA, Gabrielli A, Muller-Ladner U, Tyndall A, Matucci-Cerinic M, Distler O. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009, 68:163-168. 10.1136/ard.2008.091918, 18653485.
19. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006, 27:2247-2255. 10.1093/eurheartj/ehl198, 16912055.
20. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, Wen Y, Rapp JA, Kessler J. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008, 299:925-936. 10.1001/jama.299.8.925, 18314435.
21. Hicks C, Wong R, Manoharan A, Kwan YL. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Ann Hematol 2007, 86:591-598. 10.1007/s00277-007-0297-3, 17492259.
22. Voltarelli JC, Couri CE. Stem cell transplantation for type 1 diabetes mellitus. Diabetol Metab Syndr 2009, 1:4. 10.1186/1758-5996-1-4, 2758595, 19825196.
23. Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 2006, 55:1232-1238. 10.1016/j.metabol.2006.05.008, 16919544.
24. Anderson RA, Evans ML, Ellis GR, Graham J, Morris K, Jackson SK, Lewis MJ, Rees A, Frenneaux MP. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 2001, 154:475-483. 10.1016/S0021-9150(00)00499-8, 11166782.
25. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005, 45:1441-1448. 10.1016/j.jacc.2004.12.074, 15862416.
26. Keymel S, Kalka C, Rassaf T, Yeghiazarians Y, Kelm M, Heiss C. Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res Cardiol 2008, 103:582-586. 10.1007/s00395-008-0742-z, 18704258.
27. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002, 25:1129-1134. 10.2337/diacare.25.7.1129, 12087009.